BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29674411)

  • 1. Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma.
    Chen IE; Swinburne N; Tsankova NM; Hefti MM; Aggarwal A; Doshi AH; Hormigo A; Delman BN; Nael K
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1039-1046. PubMed ID: 29674411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
    Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
    Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
    Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
    Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
    Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
    Caravan I; Ciortea CA; Contis A; Lebovici A
    Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
    Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U
    J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.
    Nowosielski M; Recheis W; Goebel G; Güler O; Tinkhauser G; Kostron H; Schocke M; Gotwald T; Stockhammer G; Hutterer M
    Neuroradiology; 2011 Apr; 53(4):291-302. PubMed ID: 21125399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging.
    Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M
    Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of apparent diffusion coefficient parameters for glioma grading.
    Wang Q; Zhang J; Xu X; Chen X; Xu B
    J Neurooncol; 2018 Aug; 139(1):61-68. PubMed ID: 29574566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade.
    Yazdani M; Rumboldt Z; Tabesh A; Giglio P; Schiarelli C; Morgan PS; Spampinato MV
    Clin Imaging; 2018; 52():88-94. PubMed ID: 30032069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model.
    Sui Y; Xiong Y; Jiang J; Karaman MM; Xie KL; Zhu W; Zhou XJ
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1643-9. PubMed ID: 27256851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
    Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K
    AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
    McDonald CR; Delfanti RL; Krishnan AP; Leyden KM; Hattangadi-Gluth JA; Seibert TM; Karunamuni R; Elbe P; Kuperman JM; Bartsch H; Piccioni DE; White NS; Dale AM; Farid N
    Neuro Oncol; 2016 Nov; 18(11):1579-1590. PubMed ID: 27106406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability.
    Han X; Suo S; Sun Y; Zu J; Qu J; Zhou Y; Chen Z; Xu J
    J Magn Reson Imaging; 2017 Mar; 45(3):722-730. PubMed ID: 27527072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?
    Rose S; Fay M; Thomas P; Bourgeat P; Dowson N; Salvado O; Gal Y; Coulthard A; Crozier S
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):758-64. PubMed ID: 23079407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.